TERAPIA

RHINXYL HA CHILDREN 0.5MG/ML NASAL SPRAY

You're reading an Auto-translation.

Composition.

The active substance is xylometazoline hydrochloride. 1 ml of RHINXYL HA 0.5 mg/ml nasal spray, solution contains 0.5 mg of xylometazoline hydrochloride. One spray (70 µl) contains 0.035 mg of xylometazoline hydrochloride. The excipients are purified seawater, potassium dihydrogen phosphate, sodium hyaluronate, purified water.

Therapeutic indications.

RHINXYL nasal spray, solution belongs to a group of medicines for the treatment of nasal diseases, called sympathomimetics. It contains xylometazoline hydrochloride, which helps to constrict the capillary blood vessels in the nose, thus reducing the congestion of the nasal mucosa.

RHINXYL solution also contains hyaluronic acid (in the form of sodium hyaluronate), which protects and moisturises the nasal mucosa.

RHINXYL solution is used for:

- reducing nasal congestion caused by inflammation of the nasal mucosa (rhinitis) or inflammation of the sinus mucosa (sinusitis).

Dosage and method of administration.

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Dosage

Children aged 2 to 12 years: 1 spray of RHINXYL HA 0.5 mg/ml nasal spray, solution in each nostril, up to 3 times a day. RHINXYL HA 0.5 mg/ml nasal spray, solution should not be used for more than 5 days, unless otherwise prescribed by a doctor.

Use may be repeated if treatment has been interrupted for a few days.

In the case of chronic colds, RHINXYL HA 0.5 mg/ml nasal spray, solution should be used under medical supervision to prevent atrophy (thinning) of the child's nasal mucosa.

Do not use higher doses than the recommended doses.

Precautions.

Before using RHINXYL, talk to your doctor or pharmacist:

- if your child is being treated with monoamine oxidase inhibitors (MAOIs) (e.g. tranylcypromine and moclobemide, which are used to treat depression) or has used MAOIs within the last 2 weeks, tricyclic or tetracyclic antidepressants or other medicines that can increase blood pressure

- if your child is using medicines from the group of beta-blockers or alpha-blockers (commonly used to lower blood pressure or to treat benign prostatic hypertrophy (enlargement))

Special warnings.

Pregnancy, breastfeeding and fertility

This concentration of RHINXYL HA 0.5 mg/ml nasal spray, solution is intended for use in children. However, this information applies to the active substance, xylometazoline hydrochloride. If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. There are no adequate data on the use of xylometazoline hydrochloride in pregnant women. Therefore, RHINXYL HA 0.5 mg/ml nasal spray, solution should not be used during pregnancy. This medicine should not be used during breastfeeding, as it is not known whether xylometazoline hydrochloride is excreted in human milk.

Driving and using machines

No reduction in the ability to drive or operate machinery is expected if the medicine is used as directed.

Packaging. 10 ml of solution in a white plastic bottle with a dosing pump, an applicator tip and a protective cap, packed in a box.

Page updated on: 08.06.2021